At a glance
ClinicalIndex Comparison RecordN/ACompleted· 68 enrolled
Drug / intervention
iCAST™ Rx Stent Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
ARTISAN: iCAST™ RX De Novo Stent Placement for the Treatment of Atherosclerotic Renal Artery Stenosis in Patients With Resistant Hypertension
In Brief
A clinical study evaluating iCAST™ Rx Stent System for Renal Artery Stenosis and Hypertension, Renovascular. Completed, enrolled 68 participants across 12 sites.
Detailed Summary
The purpose of this trial is to test how well the iCAST™ RX Stent works in patients diagnosed with atherosclerotic renal artery stenosis and whether or not increased blood flow by the stent will help to control blood pressure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Artery Stenosis, Hypertension, Renovascular
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 2012
Enrollment StartOct 2012
Primary CompletionJun 2018
Study CompletionOct 2020
TodayJul 2026
First PostedAug 28, 2012
Enrollment StartOct 23, 2012
Primary CompletionJun 27, 2018
Study CompletionOct 26, 2020
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 13.8 years ago
Interventions
iCAST™ Rx Stent Systemdevice
All enrolled subjects will undergo primary stenting of the target lesion(s) by placement of the iCAST™ RX Stent System.